Skip to main content
Figure 1 | Trials

Figure 1

From: Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)

Figure 1

Kaplan-Meier estimates of the cumulative rate of; A. The composite primary end point of death from any cause, recurrent infarction and unstable angina within one year (intention to treat analysis). Viable invasive vs. viable conservative strategy. B. The composite primary end point of death from any cause, recurrent infarction and unstable angina within one year (per protocol analysis). Viable invasive vs. viable conservative strategy. C. The composite primary end point of death from any cause, recurrent infarction and unstable angina within one year (per protocol and adjusted for 2 days PCI delay). Viable invasive vs. viable conservative strategy. D. The composite primary end point of death from any cause, recurrent infarction and unstable angina within one year (intention to treat analysis). Patients who were treated with thrombolysis vs. patients who did not receive thrombolysis. E. The need for revascularization procedures after discharge and within one year. Viable invasive vs. viable conservative strategy. F. The need for revascularization procedures after discharge and within one year. Patients who were treated with thrombolysis vs. patients who did not receive thrombolysis. G. The primary composite endpoint (death, recurrent infarction and unstable angina) within one year. Non-viable patients (registry) vs. viable conservative patients (randomized). H. The cumulative rate of ischemic events (recurrent infarction and unstable angina) within one year. Non-viable patients (registry) vs. viable conservative patients (randomized).

Back to article page